Targeting KIF18A triggers antitumor immunity and enhances efficiency of PD-1 blockade in colorectal cancer with chromosomal instability phenotype
Abstract Colorectal cancer with chromosomal instability (CIN+) phenotype is immunosuppressive and refractory to immune checkpoint blockade (ICB) therapy. Recently, KIF18A is found to be a mitotic vulnerability in chromosomally unstable cancers, but whether targeting KIF18A affects antitumor immunity...
Saved in:
| Main Authors: | Gang Liu, Yan Zhang, Zhen Cao, Zhanwei Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-04-01
|
| Series: | Cell Death Discovery |
| Online Access: | https://doi.org/10.1038/s41420-025-02437-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting chromosomally unstable tumors with a selective KIF18A inhibitor
by: Aaron F. Phillips, et al.
Published: (2025-01-01) -
Methionine Metabolism Dictates PCSK9 Expression and Antitumor Potency of PD‐1 Blockade in MSS Colorectal Cancer
by: Qi‐Long Wang, et al.
Published: (2025-05-01) -
Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity
by: Yoichiro Narikawa, et al.
Published: (2025-08-01) -
PD-1 blockade employed at the time CD8+ T cells are activated enhances their antitumor efficacy
by: Douglas G McNeel, et al.
Published: (2025-05-01) -
Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects
by: Maria Jure-Kunkel, et al.
Published: (2025-04-01)